Literature DB >> 24019790

Corneal confocal microscopy anomalies associated with cowden syndrome: a case report.

Sandro Sbordone1, Alfonso Savastano, Maria Cristina Savastano, Vito Romano, Mario Bifani, Silvio Savastano.   

Abstract

PURPOSE: To describe bilateral corneal alterations through confocal microscopy in a patient affected by Cowden syndrome (CS).
METHODS: Evaluation of Schirmer's, fluorescein, and lissamine green dye tests. Confocal microscopy was performed in both eyes to investigate corneal abnormalities.
RESULTS: Slit lamp observation showed the focal involvement of anterior stromal and epithelial layers. Schirmer's, fluorescein, and lissamine green dye test results were regular, while corneal confocal examination confirmed the disorganization of anterior stromal and epithelial layers in both eyes.
CONCLUSION: CS is a rare autosomal-dominant systemic disorder. In our case, confocal analysis revealed predominance of alterations in the anterior stromal corneal layer, showing an increase of reflectivity, and a totally unstructured architecture in the epithelium layer. Even though the main purpose remains the prevention and the early diagnosis of different systemic tumors that could occur in affected patients, corneal confocal evaluation could play an important role in the early diagnosis of this rare disease.

Entities:  

Keywords:  Corneal alterations; Corneal confocal microscopy; Cowden syndrome; Multiple hamartoma syndrome

Year:  2013        PMID: 24019790      PMCID: PMC3764966          DOI: 10.1159/000350316

Source DB:  PubMed          Journal:  Case Rep Ophthalmol        ISSN: 1663-2699


Introduction

Cowden syndrome (CS) was first described in 1963 by Lloyd and Dennis [1]. CS is among a larger group of diseases also known as multiple hamartoma syndrome [2]. It is a rare, autosomal-dominant, multisystemic disorder characterized by diffuse hamartomatous tissue overgrowth and increased risk of breast, thyroid, and endometrial cancers [3, 4]. Approximately 80% of cases seem to arise from germline mutations in the PTEN gene (phosphatase and tensin homologue gene, 10q22–23 locus) gene, which is a tumor suppressor gene [5]. Clinically, germline mutations in PTEN have also been associated with Bannayan-Riley-Ruvalcaba syndrome, Proteus or Proteus-like syndrome, adult Lhermitte-Duclos disease and autism-like disorders [6]. Gicquel et al. [7] reported a possible correlation of CS with retinal angioma and, more recently, Mansoor and Steel [8] described a case report of proliferative retinopathy in CS. We report the case of a young female patient affected by CS, who complained of ocular discomfort and epiphora. She came to our observation for a complete ophthalmological evaluation in order to establish a possible correlation between CS and ocular disease.

Materials and Methods

Our case report describes a 14-year-old female patient. She complained of severe epiphora and photophobia over the last 2 years. The study adhered to the Declaration of Helsinki, receiving written informed consent from the parents of the minor in order to capture images of the patient's eyes. A complete ophthalmological evaluation was performed, including: best-corrected visual acuity (BCVA) in Early Treatment Diabetic Retinopathy Study (ETDRS) letters, and biomicroscopy of anterior and posterior segments. Her BCVA was 33 ETDRS letters in each eye. Both eyes were normal except for the anterior segment. Slit lamp examination showed diffuse corneal epithelial alterations with tiny fibrosis of the anterior corneal stroma and whitish epithelial dots (fig. 1a–f). Schirmer's test with topical anesthesia, and fluorescein and lissamine green dye tests were performed. In order to investigate the microscopy details of the cornea, confocal evaluation was carried out with corneal Z-ring (Confoscan 4, Nidek Technologies, Padua, Italy). The patient underwent confocal examination after local anesthesia with 2 drops of oxybuprocaine hydrochloride 0.4%.
Fig. 1

a Frontal eye image showing white conjunctiva with no signs of irritation and central corneal opacity (black arrowhead). b Slit lamp peripheral cornea observation with tiny subepithelium fibrosis (white arrowhead). c, e, f Slit lamp observations of the central, paracentral and peripheral corneal regions, respectively, show focal white dots corresponding to the alterations (white arrows) in the basal epithelium and in the anterior stromal layer. d Fluorescein dye test revealed no corneal or conjunctival defects.

Results

Schirmer's test with topical anesthesia was normal in both eyes, with tear production of more than 15 mm in 5 min (fig. 1d) [9]; fluorescein and lissamine green dye tests were negative. Confocal analysis was considered necessary to obtain the objective and microscopically defined image of the cornea. Although the density of keratocyte cells was normal in posterior and intermediate corneal stroma (495.2 and 795.6 cells/mm2, respectively), it was reduced in the anterior stroma (300.2 cells/mm2) (fig. 2). Stromal reflectivity was normal in posterior and intermediate layers, and the stromal nerves looked normal as well. However, stromal reflectivity was higher than normal in the anterior stroma and the nervous sub-basal nerve plexus was not appreciable. The thickness of the corneal epithelial layer was approximately 30 µm, showing a decrease with respect to the normal value of 50 µm [10]; also, the regular architecture had disappeared. The Bowman's layer revealed irregular fibrosis (fig. 2). A well-ordered epithelial structure from basal cells to superficial cells was not appreciable and enlarged activated epithelial cells, with highly reflective nuclei, were observable, as occurs in inflammatory chronic disease [11] (fig. 2).
Fig. 2

a Endothelium cells showing regular density (2,665 cells/mm2) and normal, pleomorphism (71.6%) and polymegathism (20.1%). b Posterior corneal stroma with normal keratocyte density and structure (495.2 cells/mm2). c Intermediate corneal stroma showing normal cell density (795.6 cells/mm2) and reflectivity. Stromal nerve fiber looks normal. d An increase of reflectivity associated with keratocyte density reduction was observed from the anterior stroma to the pre-Bowman's layer (300.2 cells/mm2). e The Bowman's layer revealed irregular fibrosis. f Basal epithelium showing cytoplasm enlargements and hyperreflective nuclei, as occurs in inflammatory chronic diseases. g Z scan image shows reflectivity of corneal tissue (azure line), Z scan (white line) and Z ring force (green line). The letters A–F along the reflectivity line correspond to the reported images in the figure (a–f).

Discussion

CS is a rare disorder characterized by diffuse and small hamartomas, commonly identified on the skin and in mucous membranes (i.e. mouth and nose), even though it can also affect the intestinal region as well as other areas. Moreover, patients with CS have an increased risk of developing cancer involving the breast, thyroid, and uterus. The difficulty in diagnosing CS does not allow an exact estimate of its prevalence (1:200,000–250,000 persons) and incidence (1:1,000,000) [12]. Nowadays, prevention and early diagnosis of the development of tumors in these patients play an important role. In our report, we described corneal alterations in a young patient affected by CS. Despite the fact that the patient complained of photophobia and showed epithelial corneal alterations similar to the ones caused by a long-lasting eye drop therapy or by the chronic abuse of contact lenses, alterations to the lissamine, fluorescein and Schirmer's tests were not appreciable. Confocal analysis revealed predominance of alterations in the anterior stromal corneal layers, showing an increase of reflectivity, and a totally unstructured architecture in the epithelium layer. Multicentric investigations on a greater number of patients would be necessary to evaluate the possible correlation between CS and corneal changes. The diagnosis of CS exposes the patient to an increased risk of breast cancer (25–50% compared to 12% in the normal population), thyroid cancer (3–10% compared to 1% in the normal population) and uterine cancer (5–10% compared to 2.5% in the normal population) [6]. Once diagnosed, the patient will undergo testing for the prevention of such tumors to ensure early diagnosis. We would like to highlight this particular corneal alteration because it could be useful for early diagnosis of CS if a correlation between these 2 conditions is found in the future. Moreover, when CS is suspected, genetic investigation could reveal important information concerning this possible correlation.

Disclosure Statement

The authors have no proprietary or financial interest in any material or device mentioned.
  11 in total

1.  Cowden's disease. A possible new symptom complex with multiple system involvement.

Authors:  K M LLOYD; M DENNIS
Journal:  Ann Intern Med       Date:  1963-01       Impact factor: 25.391

2.  Proliferative retinopathy in Cowden syndrome.

Authors:  Qasim Mansoor; David H W Steel
Journal:  BMJ Case Rep       Date:  2012-03-08

3.  Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.

Authors:  Joanne Ngeow; Jessica Mester; Lisa A Rybicki; Ying Ni; Mira Milas; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

Review 4.  Colonic ganglioneuromatous polyposis and metastatic adenocarcinoma in the setting of Cowden syndrome: a case report and literature review.

Authors:  Joshua W Trufant; Laura Greene; Deborah L Cook; Wendy McKinnon; Marc Greenblatt; Marcus W Bosenberg
Journal:  Hum Pathol       Date:  2011-10-21       Impact factor: 3.466

Review 5.  Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with Cowden syndrome, autistic disorder, and epilepsy.

Authors:  Sara Conti; Maria Condò; Annio Posar; Francesca Mari; Nicoletta Resta; Alessandra Renieri; Iria Neri; Annalisa Patrizi; Antonia Parmeggiani
Journal:  J Child Neurol       Date:  2011-09-29       Impact factor: 1.987

6.  Morphological evaluation of normal human corneal epithelium.

Authors:  Niels Ehlers; Steffen Heegaard; Jesper Hjortdal; Anders Ivarsen; Kim Nielsen; Jan Ulrik Prause
Journal:  Acta Ophthalmol       Date:  2010-12       Impact factor: 3.761

7.  Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations.

Authors:  M R Nelen; H Kremer; I B Konings; F Schoute; A J van Essen; R Koch; C G Woods; J P Fryns; B Hamel; L H Hoefsloot; E A Peeters; G W Padberg
Journal:  Eur J Hum Genet       Date:  1999-04       Impact factor: 4.246

8.  Cowden's syndrome: a clinical, immunological, and histopathological study.

Authors:  Mohamed Amer; Fawzia Farag Mostafa; Enayat Mohamed Attwa; Samia Ibrahim
Journal:  Int J Dermatol       Date:  2011-05       Impact factor: 2.736

9.  Retinal angioma in a patient with Cowden disease.

Authors:  Jean-Jacques Gicquel; Pierre Vabres; Dominique Bonneau; Martial Mercié; Latifa Handiri; Paul Dighiero
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

Review 10.  Cowden syndrome: a critical review of the clinical literature.

Authors:  Robert Pilarski
Journal:  J Genet Couns       Date:  2008-10-30       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.